Medical Communications
Sanofi lowers Q3 sales figures from 2015
October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cipro, Plavix, Sanofi, financial results
New treatment for leukaemia nullifies cancer cells
October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boston, Cancer, Germany, Harvard, Mainz University, leukaemia
Sun Pharmaceuticals hit with recall of over 31 thousand bottles of anti-depressants
October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, India, US, america, sun pharmaceutical
Novartis’ Zykadia more effective than chemo, new study shows
October 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alcensa, Novartis, Roche, Xalkori, ceritinib, crizotinib, lung cancer, zykadia
Nestlé appoints Paul Navarre as CEO of Nestlé Skin Health
October 12, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Nestle skin health, Paul Navarre, nestle
Sanofi appoint Alan Main to Executive Committee and Executive Vice President Consumer Healthcare
October 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
New UK & Ireland general manager for Teva
October 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, appointment
Educating pharma
October 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing educated, funding, medical education, transparency
Mylan agrees $465m settlement over EpiPen misclassification
October 10, 2016 Business Services, Medical Communications, Sales and Marketing Heather Bresch, Mylan, Price hike, epipen
NICE recommends Forxiga in Triple Therapy for Diabetes
October 7, 2016 Medical Communications AstraZeneca, Forxiga, NHS, NICE, diabetes, type 2 diabetes
Cancer Research UK receives ‘success payment’ from GlaxoSmithKline
October 7, 2016 Medical Communications GSK, GlaxoSmithKline, University of Manchester, cancer research
Top Ten articles in the Pharma Industry this week
October 7, 2016 Medical Communications
AstraZeneca sells off third drug in five days
October 7, 2016 Medical Communications AstraZeneca, Cilag GmbH, Johnson & Johnson, Rhinocort Aqua
ICU Medical to acquire Pfizer’s global infusion therapy business in $1 billion deal
October 6, 2016 Medical Communications Hospira, ICU medical, Pfizer, acquisition, infusion
“Incorrect classification” of EpiPen leads to $1 billion bill for US government
October 6, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, Heather Bresch, Misclassification, Mylan, Price hike, classification, epipen, price, scandal
Latest content
MedPharm appoints Jason Mieding as chief operating officer
Coriolis Pharma appoints Teun van der Heide as CEO
The evidence bar impacting UK medical cannabis access
